EP3092252
ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.1.2015EP published:
18.9.2019EP application number:
15701442.4
EPO information:
European Patent Register
Max expiry date:
7.1.2035
Title:
ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF
Timeline
Today
8.1.2015EP application
18.9.2019EP Publication
Owner
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, 20892-7660, Bethesda, MD, US
Name:
University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures GroupAddress:
250 West Main Street, Suite 300, 22902, Charlottesville, VA, US
Inventor
Name:
WIESTNER, Adrian U.Address:
Bethesda, Maryland, US
Name:
SKARZYNSKI, Martin W.Address:
North Bethesda, Maryland, US
Name:
LINDORFER, Margaret A.Address:
Keswick, Virginia, US
Name:
TAYLOR, Ronald P.Address:
Keswick, Virginia, US
Name:
RADER, ChristophAddress:
Jupiter, Florida, US
Name:
VIRE, BérengèreAddress:
Les Matelles, FR
Priority
Number:
201461924967 PDate:
8.1.2014Country:
US
Classification
Categories:
C07K 16/18, C07K 16/30, A61P 35/02, C07K 14/725, C07K 14/47, A61K 39/00